17 th october cener
play

17 th October, CENER The ABE Process: A History Lesson ABE A cetone, - PowerPoint PPT Presentation

Clostridial Strain Development: Improving the ABE process Holly Smith Biomass for sustainable biofuels & biobased products: From lab to pilot plant 17 th October, CENER The ABE Process: A History Lesson ABE A cetone, B utanol, E thanol


  1. Clostridial Strain Development: Improving the ABE process Holly Smith Biomass for sustainable biofuels & biobased products: From lab to pilot plant 17 th October, CENER

  2. The ABE Process: A History Lesson ABE – A cetone, B utanol, E thanol • A long history of solvents produced by fermentation – Bio-butanol (Pasteur) 1861 – Bio-acetone 1905 • The Weizmann process for ABE patented in 1915 • First ABE plant (UK) 1916 Deployment globally between the 1 st and 2 nd World Wars • • Production in Russia and South Africa into the 1980s • Production in China in 2000s Private and confidential 2

  3. Central Minnesota Renewables • Bio-based n-butanol and acetone • Re-purposed ethanol plant • Capital efficient and cost competitive • First customer shipments December 2016 Little Falls, Minnesota Private and confidential 3

  4. Market diversity Private and confidential 4

  5. Our Technology Research Expertise Underpinning Technology Unique culture collection for solvent-producing Clostridium Microbes bacteria and genes for optimization. Strain evolution for optimal performance in the Advanced Fermentation Process (AFP ™ ). Strain Development New technology, CLEAVE™ for genome editing and new products AFP ™ for higher productivity, yields and recovery. Process Development Integration of bacteria and process. Private and confidential 5

  6. ABE Process : Targets for Improvements Process Improvements Butanol tolerance • High productivity fermentation • Continuous solvent removal Inhibitor tolerance Faster growth rates Improved sugar uptake rates Private and confidential 6

  7. Strain Development : Generating improved strains Strain improvement is linked to a number of Depending on target and genetic tractability of strains, performance targets various strategies are employed for strain development Chemical Mutagenesis Wild type • Generates multiple genotypes within a population strains • Strains selected for an improved phenotype can often have mutations in non-obvious gene targets Rational Strain Spontaneous Adaptive Laboratory Evolution (ALE) Improvements mutants • Specific environmental pressure applied to drive advantageous cell adaption Commercial strains • “Natural” selection means the resulting cultures are generally healthy and robust for scale up process Rational Strain Improvement • NGS – sequence mutant strain libraries with potentially Adaptive Lab Chemical beneficial mutations Evolution Mutagenesis • Build “superior strains” by introducing single or layered mutations in a clean genetic background Private and confidential 7

  8. 8

  9. ButaNext Strain Development • Develop next generation biobutanol using sustainable feedstocks Aim • Need a high productivity, homofermentative process • Requires tolerance to high concentrations of product Challenges and inhibitors present in feedstocks • Strain selection using ALE: Butanol and Inhibitor tolerance Strategy • Development of high productivity fermentation process 9

  10. Improving Inhibitor Tolerance Cellulosic Adaptive Laboratory AFP™ bench scale Feedstocks Evolution testing • Inhibitors • Sequential Batch • Strains tested for generated during Reactor (SBR) improvements in acidic thermo- AFP™ • Selective chemical pre- pressure – faster • Fed batch treatment growth rates in process with • Organic acids presence of cellulosic inhibitors hydrolysates and • Furfural, HMF ISPR 10

  11. Sequential Batch Reactor • Automated system whereby culture from the previous batch is used to seed fresh medium • Monitor system by on-line pH measurements and microscopy • Selecting for faster growth rates on C6/C5 blended representative lignocellulosic feedstock 11

  12. Inhibitor tolerant SBR strain testing • Results shown are normalised to the control strain – values >1 demonstrates improvement. • Strains from the SBR were tested in AFP™ using the same representative cellulosic feedstock • Testing in a fed batch process with feed containing high concentration of a C6/C5 blend of sugars • Strains 1 and 2 showed significant improvements in total ABE productivity and sugar uptake rate compared to the parent control strains • Indicative of tolerance to feedstock inhibitors 12

  13. AFP™ testing using ButaNext Feedstocks • Hydrolysates of miscanthus and wheat straw feedstocks were provided by CENER and tested in GBL’s AFP™ systems • Testing blend of C6/C5 sugars, with an initial batch of approx. 15 g/L sugars to reduce inhibitor effect • Aimed to keep glucose concentration below 1 g/L during fed batch phase to prevent xylose build-up • Results shown are normalised to the control strain – productivity >1 demonstrates improvement • Strain 1 showed significant improvements over the parental strain with miscanthus feedstock • Slightly diminished performance using wheat straw hydrolysate. • Tests performed using standard conditions for AFP™ • Optimisation of AFP™ conditions may improve metrics further. 13

  14. Summary • Green Biologics – Established business with operating commercial plant − Targeting specialty chemical market with high value applications − Development of new processes important to drive innovation and commercialisation of biofuels. • Improving economics of biobutanol as a next generation biofuel – Cost effective feedstocks – Strain development & high productivity fermentation important for economics of process – Adaptive laboratory evolution is a powerful tool for selection of robust strains with improved tolerance to feedstock inhibitors. Private and confidential 14

  15. Acknowledgements ButaNext partners CENER Kimberley Baker Abdul Saqib Rachel Harper Dannielle Kydd-Sinclair Barnabas Owoh Yatin Behl Tim Davies Private and confidential 15

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend